ADA 2019 guideline on antibiotics for pulpal and periapical pain: the answer is almost always no, and the strongest recommendation is the one against the adjunctive script

What it says#

An expert panel convened by the ADA Council on Scientific Affairs and the Center for Evidence-Based Dentistry asked a narrow question: for an immunocompetent adult with a pulpal or periapical condition, does an oral systemic antibiotic improve outcomes, either alone or added to definitive treatment? It searched MEDLINE, Embase, the Cochrane Library and CINAHL, graded the evidence with GRADE, and worked through the Evidence-to-Decision framework. The answer, in almost every scenario it examined, is no.

The numbers behind the verdict run in one direction. From randomized trials, the desirable effects were judged potentially negligible: 24 hours after starting antibiotics pain intensity may increase slightly, and after seven days it may reduce slightly, low certainty; in absolute terms, across time points up to seven days, out of 1,000 people taking antibiotics anywhere from 49 fewer to 100 more may experience pain. From observational studies the panel identified a large burden of harm, including mortality from antibiotic-resistant infections, community-associated Clostridioides difficile infection and its mortality, and anaphylaxis, at moderate certainty. The context it opens with is that general and specialty dentists are the third highest prescribers of antibiotics in all outpatient settings in the United States, and that current reports suggest 30% to 85% of dental antibiotic prescriptions are suboptimal or not indicated.

Where definitive treatment is not an immediate option, the panel gives four answers. For symptomatic irreversible pulpitis with or without symptomatic apical periodontitis, it recommends dentists do not prescribe oral systemic antibiotics and refer for definitive, conservative dental treatment while providing interim monitoring, a strong recommendation on low certainty in the evidence. Its reasoning is physiologic as well as statistical: the inflamed pulpal tissue in this condition is not an infection. For pulp necrosis with symptomatic apical periodontitis, it suggests dentists do not prescribe, refer, and provide a delayed prescription for amoxicillin 500 mg three times a day for 3 to 7 days or penicillin VK 500 mg four times a day for 3 to 7 days only if definitive treatment is not feasible, a conditional recommendation on very low certainty; the patient is told to fill it if swelling or pus appears. For pulp necrosis with localized acute apical abscess, it suggests those same regimens plus urgent referral, conditional on very low certainty. For acute apical abscess with systemic involvement, a good practice statement gives the same antibiotic plus urgent referral, with emergent evaluation if the condition worsens or there is concern for a deeper space infection or an immediate threat to life.

Where definitive treatment can be done the same visit, there are two answers and both are against the script. For pulp necrosis with symptomatic apical periodontitis or localized acute apical abscess, the panel recommends dentists do not prescribe an antibiotic as an adjunct to definitive treatment: a strong recommendation, on very low certainty in the evidence. For symptomatic irreversible pulpitis with or without symptomatic apical periodontitis, it suggests the same, conditional on very low certainty. Only systemic involvement changes the answer, and there the good practice statement is to perform urgent definitive treatment in conjunction with the antibiotic, not instead of it.

The regimen footnotes carry the rest of the prescribing detail, all adult. Amoxicillin is preferred over penicillin VK because it is more effective against various gram-negative anaerobes and has a lower incidence of gastrointestinal side effects. For a penicillin allergy without a history of anaphylaxis, angioedema or hives, cephalexin 500 mg four times a day for 3 to 7 days, with a low threshold to add metronidazole if the response is delayed. With a history of anaphylaxis, angioedema or hives, azithromycin with a 500 mg loading dose on day 1 followed by 250 mg for four more days, or clindamycin 300 mg four times a day for 3 to 7 days; the panel flags that azithromycin resistance rates are higher than for other antibiotics and that clindamycin carries an FDA boxed warning for C. difficile infection. If first-line treatment fails in a patient without penicillin allergy, complement it with metronidazole 500 mg three times a day for 7 days, or discontinue it and prescribe amoxicillin and clavulanate 500/125 mg three times a day for 7 days. Reevaluate within 3 days by visit or phone, and instruct the patient to stop the antibiotic 24 hours after symptoms resolve regardless. For the pain itself the guideline points to nonsteroidal anti-inflammatory drugs and acetaminophen, specifically 400 to 600 mg ibuprofen plus 1,000 mg acetaminophen.

Who it applies to#

Immunocompetent adults 18 and older, without additional comorbidities, presenting with one of the target conditions. The management of adults with cellulitis or compromised immune systems is outside the scope, and so is the management of adults undergoing tooth extraction. Children are outside it too. The recommendations are written primarily for general dentists, and the guideline names emergency and primary care physicians in its audience because dental pain is the most cited oral health reason for contacting an emergency department, where pulp vitality testing is not available and a prescription is often the only thing on offer.

It is a clinical practice guideline, not a rule, and it says so: clinicians should use informed clinical judgment to identify the appropriate course of action in situations that deviate from the recommendations. This entry reports the guideline; the treating dentist decides. Read it next to the pain guidelines, because the two documents answer different halves of the same emergency visit: this one says the antibiotic is usually wrong, and ada-acute-dental-pain-adults-2024 says what to reach for instead. Prophylaxis before a procedure is a third question entirely, covered in aha-viridans-endocarditis-prophylaxis-2021.

What changed#

First edition. Other countries and guideline groups had published recommendations on systemic antibiotics for pulpal and periapical infections, but there were no ADA guidelines for dentists in the United States before this one, and the guideline says so in its introduction. Against common practice the change is large, since the panel's own citation is that 30% to 85% of dental antibiotic prescriptions are suboptimal or not indicated. The panel committed to updating the document whenever the direction or strength of a recommendation may be affected by newly published evidence, or within five years.

Where the source is#

The link under the title is the ADA's own page for the guideline, which carries both chairside guides as PDFs: one for urgent situations in which definitive, conservative dental treatment is immediately available, one for when it is not. Each is two pages, with the recommendation table and its certainty and strength on one side and the clinical pathway on the other, copyright 2019 American Dental Association, free to copy and distribute for noncommercial purposes. The guideline itself was published in JADA 2019;150(11):906-921.e12; jada.ada.org refused automated access in this session, so the full text above, including the recommendation table, its footnotes, the GRADE definitions and the effect estimates, was read from the author manuscript deposited in PubMed Central as PMC8270006, which carries the complete text and appendices. The PubMed record is PMID 31668170. The accompanying systematic review is cited within the guideline and was not read here.